Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Blackbird, Sareum insiders pick up shares

(Sharecast News) - Blackbird found itself with a number of entries on the list of director buys on Wednesday, after a number of insiders and associates bought shares.

The cloud-based video editing technology company said chief executive officer Ian McDonough, his associate Syarifah Aidid, and its research and development director Stephen Streater all made purchases.

It said McDonough picked up 225,000 shares for 8.7p each, while Streater purchased 125,000 shares at 8.5p apiece.

Aidid purchased shares across four transactions, buying 62,389 for 7.995p each, 63,380 for 7.87p each, 56,754 for 8.7888p each, and 56,754 for 8.7888p each as well.

Blackbird said all of the transactions were made on 5 September.

"Following the above purchases, Ian McDonough and his wife, Syarifah Aidid, now have a total beneficial interest in 10,029,656 ordinary shares, equivalent to approximately 2.72% of the company's issued share capital, and Stephen Streater now has a total beneficial interest in 62,785,000 ordinary shares, equivalent to approximately 17.05% of the company's issued share capital," Blackbird said in its disclosure.

Elsewhere, biotechnology company Sareum Holdings disclosed that non-executive chairman Dr Stephen Parker had purchased 12,500 of its shares at an average price of 80p each, also on 5 September.

In addition, it said associates of Dr Parker were interested in a further 25,680 shares in the Company, over which he had voting rights discretion.

"Therefore, following the transaction, Dr Parker has direct and indirect interests in an aggregate 116,160 ordinary shares in the company, representing approximately 0.16% of the company's currently issued share capital," Sareum confirmed.

At the close on Wednesday, shares in Blackbird were up 5.88% at 9p, while those in Sareum Holdings were ahead 3.12% at 82.5p.

Reporting by Josh White for Sharecast.com.

Top Director Buys

(BIRD) Director name: McDonough,Ian Amount purchased: 225,000 @ 8.70p Value: �19,575.00

(BIRD) Director name: Streater,Stephen Amount purchased: 125,000 @ 8.50p Value: �10,625.00

Sareum Holdings (SAR) Director name: Parker,Stephen Amount purchased: 12,500 @ 80.00p Value: �10,000.00

(BIRD) Director name: McDonough,Ian Amount purchased: 63,380 @ 7.87p Value: �4,988.01

(BIRD) Director name: McDonough,Ian Amount purchased: 62,389 @ 8.00p Value: �4,988.00

(BIRD) Director name: McDonough,Ian Amount purchased: 56,754 @ 7.89p Value: �4,476.76

(BIRD) Director name: McDonough,Ian Amount purchased: 56,754 @ 7.89p Value: �4,476.76

Gran Tierra Energy Inc. (cdi) (GTE) Director name: Guidry,Gary Amount purchased: 572 @ $6.42 Value: $3,028.15

Capita (CPI) Director name: Weller,Tim Amount purchased: 968 @ 17.81p Value: �172.43

Capita (CPI) Director name: Lewis,Jonathan (Jon) Amount purchased: 968 @ 17.81p Value: �172.43

Share this article

Related Sharecast Articles

Director dealings: Jadestone CEO snaps up shares
(Sharecast News) - Jadestone Energy revealed on Wednesday that chief executive Alexander Blakeley had acquired 443,100 ordinary shares in the AIM-listed upstream production company.
Director dealings: Travis Perkins CEO snaps up shares
(Sharecast News) - Travis Perkins revealed on Tuesday that chief executive Pete Redfern had acquired 249,218 ordinary shares in the FTSE 250-listed builders' merchant.
Director dealings: Arcontech CEO invests, Hargreaves Services director conducts sale-and-repurchase
(Sharecast News) - Matthew Jeffs, chief executive officer of Arcontech Group, disclosed a series of personal share purchases in the company on Monday, amounting to a total of 60,000 ordinary shares.
Director dealings: Haleon's Alan Stewart snaps up shares
(Sharecast News) - Haleon revealed on Friday that non-executive director Alan Stewart had acquired 33,923 ordinary shares in the London-listed consumer healthcare business.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.